Alessandra Cesano
Board Member
Summit Therapeutics Inc. (SMMT)Board Member
Puma Biotechnology, Inc. (PBYI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alessandra Cesano
Alessandra Cesano is recorded as Board Member at Summit Therapeutics Inc. (SMMT) and Board Member at Puma Biotechnology, Inc. (PBYI). Summit Therapeutics Inc. reported in an 8-K filed November 17, 2022 that Alessandra Cesano was appointed director, effective November 15, 2022.
“Effective on November 15, 2022, the board of directors (the "Board") of Summit Therapeutics Inc. (the "Company") unanimously approved (i) the election of Dr. Alessandra Cesano, MD, PhD as a director of the Company”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Current
2022-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Puma Biotechnology, Inc.
Other people whose current roles at this company are on record from its filings.
- Alan Auerbach CEO, Board Member
- Alan H. Auerbach CEO, Board Member
- Maximo Nougues CFO
- Adrian M. Senderowicz Board Member
- Allison Dorval Board Member
- Brian Stuglik Board Member
- Jay M. Moyes Board Member
- Michael P. Miller Board Member
- Troy E. Wilson Board Member
Leadership on record at Summit Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Glyn Edwards CEO
- Mahkam Zanganeh CEO, COO, Board Member
- Robert Duggan CEO, Board Member
- Manmeet Soni CFO, Board Member
- Dr. Mahkam Zanganeh COO, Board Member
- Manmeet S. Soni COO
- Bhaskar Anand Chief Accounting Officer
- Jeffrey R. Maranian Chief Accounting Officer
- Dr. Alessandra Cesano, MD, PhD Board Member
- Dr. Michael Wang Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.